ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/01 | 1,112 | 1,125 | 1,081 | 1,087 | -25 | -2.2% | 671,000 |
2019/01/31 | 1,100 | 1,142 | 1,074 | 1,112 | +38 | +3.5% | 1,326,900 |
2019/01/30 | 1,149 | 1,164 | 1,069 | 1,074 | -161 | -13% | 2,296,800 |
2019/01/29 | 1,288 | 1,297 | 1,213 | 1,235 | -52 | -4% | 1,337,100 |
2019/01/28 | 1,357 | 1,368 | 1,275 | 1,287 | -90 | -6.5% | 1,392,500 |
2019/01/25 | 1,430 | 1,444 | 1,368 | 1,377 | -83 | -5.7% | 2,892,100 |
2019/01/24 | 1,250 | 1,460 | 1,221 | 1,460 | +300 | +25.9% | 5,965,300 |
2019/01/23 | 1,199 | 1,207 | 1,155 | 1,160 | -42 | -3.5% | 836,300 |
2019/01/22 | 1,220 | 1,335 | 1,142 | 1,202 | +2 | +0.2% | 2,036,900 |
2019/01/21 | 1,342 | 1,348 | 1,198 | 1,200 | -134 | -10% | 1,385,500 |
2019/01/18 | 1,256 | 1,339 | 1,253 | 1,334 | +75 | +6% | 1,060,500 |
2019/01/17 | 1,235 | 1,264 | 1,222 | 1,259 | +33 | +2.7% | 532,700 |
2019/01/16 | 1,240 | 1,252 | 1,221 | 1,226 | -1 | -0.1% | 356,700 |
2019/01/15 | 1,205 | 1,250 | 1,198 | 1,227 | -8 | -0.6% | 435,800 |
2019/01/11 | 1,218 | 1,274 | 1,213 | 1,235 | +36 | +3% | 716,700 |
2019/01/10 | 1,261 | 1,277 | 1,195 | 1,199 | -87 | -6.8% | 841,800 |
2019/01/09 | 1,271 | 1,306 | 1,231 | 1,286 | +10 | +0.8% | 1,060,200 |
2019/01/08 | 1,220 | 1,284 | 1,215 | 1,276 | +61 | +5% | 1,233,400 |
2019/01/07 | 1,245 | 1,263 | 1,196 | 1,215 | +12 | +1% | 1,202,100 |
2019/01/04 | 1,150 | 1,263 | 1,066 | 1,203 | +126 | +11.7% | 3,823,100 |
2018/12/28 | 900 | 1,077 | 897 | 1,077 | +150 | +16.2% | 2,369,100 |
2018/12/27 | 899 | 943 | 870 | 927 | +84 | +10% | 1,049,000 |
2018/12/26 | 856 | 870 | 815 | 843 | +29 | +3.6% | 946,500 |
2018/12/25 | 799 | 876 | 785 | 814 | -15 | -1.8% | 2,173,000 |
2018/12/21 | 856 | 875 | 792 | 829 | -42 | -4.8% | 1,514,700 |
2018/12/20 | 935 | 976 | 853 | 871 | -79 | -8.3% | 1,684,400 |
2018/12/19 | 945 | 977 | 928 | 950 | -5 | -0.5% | 855,400 |
2018/12/18 | 1,001 | 1,008 | 955 | 955 | -82 | -7.9% | 1,179,200 |
2018/12/17 | 1,106 | 1,113 | 1,034 | 1,037 | -105 | -9.2% | 1,084,500 |
2018/12/14 | 1,104 | 1,270 | 1,067 | 1,142 | +38 | +3.4% | 1,642,900 |
2018/12/13 | 1,129 | 1,134 | 1,096 | 1,104 | +2 | +0.2% | 318,400 |
2018/12/12 | 1,052 | 1,102 | 1,047 | 1,102 | +65 | +6.3% | 439,600 |
2018/12/11 | 1,071 | 1,096 | 1,030 | 1,037 | -8 | -0.8% | 502,900 |
2018/12/10 | 1,102 | 1,114 | 1,045 | 1,045 | -87 | -7.7% | 654,100 |
2018/12/07 | 1,180 | 1,192 | 1,126 | 1,132 | -30 | -2.6% | 392,500 |
2018/12/06 | 1,230 | 1,230 | 1,157 | 1,162 | -63 | -5.1% | 593,300 |
2018/12/05 | 1,183 | 1,234 | 1,175 | 1,225 | -5 | -0.4% | 477,400 |
2018/12/04 | 1,270 | 1,307 | 1,229 | 1,230 | -38 | -3% | 634,000 |
2018/12/03 | 1,282 | 1,310 | 1,245 | 1,268 | +76 | +6.4% | 972,200 |
2018/11/30 | 1,215 | 1,224 | 1,184 | 1,192 | -32 | -2.6% | 392,200 |
2018/11/29 | 1,250 | 1,267 | 1,213 | 1,224 | -13 | -1.1% | 692,900 |
2018/11/28 | 1,140 | 1,268 | 1,129 | 1,237 | +114 | +10.2% | 1,458,800 |
2018/11/27 | 1,145 | 1,158 | 1,116 | 1,123 | -1 | -0.1% | 417,600 |
2018/11/26 | 1,124 | 1,147 | 1,106 | 1,124 | ±0 | ±0% | 339,400 |
2018/11/22 | 1,119 | 1,143 | 1,102 | 1,124 | +26 | +2.4% | 327,200 |
2018/11/21 | 1,070 | 1,130 | 1,070 | 1,098 | -2 | -0.2% | 280,900 |
2018/11/20 | 1,138 | 1,162 | 1,090 | 1,100 | -25 | -2.2% | 518,800 |
2018/11/19 | 1,061 | 1,141 | 1,061 | 1,125 | +66 | +6.2% | 455,400 |
2018/11/16 | 1,102 | 1,125 | 1,056 | 1,059 | -34 | -3.1% | 364,500 |
2018/11/15 | 1,055 | 1,100 | 1,055 | 1,093 | +38 | +3.6% | 275,900 |
1601~
1650
件表示中 / 3450件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
Chordia | 18,000円 | - | - | 0.00% | - | 3.83倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
セルソース | 62,300円 | - | - | 0.80% | 48.41倍 | 2.09倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
市場注目の銘柄
チャート関連のコラム